BioSpace News Archive

Review in Chinese Medical Journal Explores Link Between Intestinal Microbes and Metabolic Health

Metabolic syndrome constitutes a group of risk factors—including obesity, hyperglycemia, dyslipidemia, and hypertension—that increase the risk of cardiovascular and cerebrovascular diseases.

October 26, 2021
·
2 min read
BioMidwest

Bio-Detection K9 to Address SARS-COV2 Delta Variant

One of the more frightening aspects of the COVID pandemic is the development of SARS-COV2 variants with altered transmission rates.

October 26, 2021
·
3 min read
Lone Star Bio

Rapid Therapeutic Science Laboratories to Present at the Benzinga Global Small Cap Conference

Rapid Therapeutics Science Laboratories (OTC: RTSL) (“Rapid Therapeutic’’ or the “Company”), a growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds, announces today that CEO Donal Schmidt will present a corporate overview at the Benzinga Global Small Cap Conference.

October 26, 2021
·
4 min read
Pharm Country

Aruvant Announces ARU-2801 Data Oral Presentation at Society for Endocrinology BES 2021 Conference

Aruvant Sciences (“Aruvant”), a private company focused on developing gene therapies for rare diseases, announced an oral presentation at the Society for Endocrinology BES 2021 conference in Edinburgh, Scotland.

October 26, 2021
·
3 min read
Business

Vertex and Mammoth Biosciences Announce Collaboration to Develop In Vivo Gene-Editing Therapies for Serious Diseases

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Mammoth Biosciences, a biotech company building the next generation of CRISPR products to cure and detect disease, today announced a new partnership to develop in vivo gene-editing therapies for two genetic diseases using Mammoth’s next-generation CRISPR systems.

October 26, 2021
·
6 min read
Business

GlycoMimetics to Report Third Quarter Financial Results on November 2, 2021

GlycoMimetics, Inc. (Nasdaq: GLYC) announced today that it will host a conference call and webcast to report its third quarter financial results on Tuesday, November 2, 2021, at 8:30 a.m. ET.

October 26, 2021
·
1 min read
Evaxion Biotech Announces Filing of Registration Statement in the U.S for Proposed Follow-on Public Offering to Raise Additional Capital

Evaxion Biotech A/S announced today that it has filed a registration statement on Form F-1 (the “Registration Statement) with the U.S. Securities and Exchange Commission (the “SEC”)

October 26, 2021
·
5 min read
Business

Infinity Announces the Date of Its Third Quarter 2021 Financial Results Conference Call and Webcast

Infinity Pharmaceuticals, Inc . will host a conference call on Tuesday, November 2 nd 2021, at 4:30pm ET to report its financial results for the third quarter of 2021.

October 26, 2021
·
2 min read
BioNTech Plans to Initiate the Construction of an mRNA Vaccine Manufacturing Facility in Africa in mid-2022

BioNTech SE announced that the Company plans to initiate the construction of the first state-of-the-art manufacturing site for mRNA-based vaccines in the African Union in mid-2022.

October 26, 2021
·
9 min read
Biotech Beach

eFFECTOR Therapeutics to Participate in Upcoming Investor Conferences

eFFECTOR Therapeutics today announced that management will participate in and host 1x1 meetings at the following upcoming investor conferences

October 26, 2021
·
2 min read